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bDepartment of Cardiology, “Saint Andrews” State General Hospital, Patras, Achaia, GreeceDuring their everyday practice, physicians are encountering
some unexpected, peculiar, bizarre, strange, surprising,
extraordinary and astonishing events that need quick expla-
nation and emergency treatment. According to these events,
patients with coronary stent implantation who accidentally
developed an allergic reaction elsewhere in the human body
from various causes developed, contemporarily, the much
feared intrastent thrombosis. For example, acute myocardial
infarction, in the stented area, has coincided with allergic
reaction following intravenous administration of the non-
anionic contrast material iopromide during a routine excre-
tory urography.1 Stent thrombosis has been associated with
allergic symptoms such as glottis edema, cold sweat, and
tongue enlargement following a flavonate-propyphenazone
administration a week after stent implantation.2 Intrastent
thromboses have also been reported following insect and
larvae sting-induced allergic reactions.3 Late drug eluting
stent thrombosis defined as type III variant of Kounis syn-
drome4 has occurred following an allergic reaction to non
steroidal anti-inflammatory agent acemetacine.5 The aston-
ishing event is that even an allergic reaction to clopidogrel,6
the drug that is given to prevent stent thrombosis, itself has
induced stent thrombosis! An additional report published in
Indian Heart Journal7 was referred to a 60-year-oldmale patient
with stent implantation for critical left anterior descending
coronary artery stenosis who developed stent thrombosis
following a snake bite. This patient was thrombolysed and his
coronary angiogram, 5 days later, revealed patent stent with
TIMI III flow and no evidence of thrombus.
All above reports were concerning patients who were
receiving multiple medications, known to induce allergic
reactions, following stent implantation. Therefore, one can* Corresponding author.
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http://dx.doi.org/10.1016/j.ihj.2013.12.013assume that stents, like magnet, attract inflammatory cells
and constitute the area of possible mast cell and platelet
activation.1. Snake bites and IgE-mediated
hypersensitivity reactions
The described patient7 developed severe central chest pain
and hypotension few hours after he was bitten by snake. His
electrocardiogram showed ST segment elevation in the ante-
rior chest leads with echocardiographic wall motion abnor-
malities in the area of stent implantation. Administration of
inotropes and volume expansion did not improve symptoms
and the patient was successfully treated with thrombolysis.
This case raises some important questions concerning the
etiology of snake bite-associated stent thrombosis, the in-
adequacy of inotropes and volume expansion, the cause of
snake bite-induced myocardial injury and the preference of
the myocardial event to that particular stented territory.
Although the exact mechanism of snake bite-induced
myocardial injury still remains unclear, direct cardiotoxicity,
hypercoagulability, toxic myocarditis from envenomation,
vasospasm frompanic and sarafotoxin and hypovolemia have
been suggested as possible causes. However, in this case with
stent implantation, IgE-mediated allergic reaction seems
possible. The venom of snakes contains a mixture of proteins
such as amino acids, toxic peptides, metalloproteins, proteo-
lytic enzymes, peptide hydrolases, phospholipase A2, hyal-
uronidase and phosphodiesterase. All these ingredients either
themselves or as haptens attached to serum proteins can
induce allergic or anaphylactic reactions. Indeed allergic ory of India. All rights reserved.
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caria, localized angioedema and asthma have been reported
and have been attributed to mast cell mediators including
histamine.8 Several reports associate snake bites with allergic
or anaphylactic reactions9e14 and Kounis syndrome.15 In
another study16 seven of the eight patients with systemic
snake bite reactions had both positive skin tests and snake
venom-specific immunoglobulin E antibodies. Therefore, in
the described patient, with stent implantation acting as anti-
genic complex inside the coronaries,17 the development of
stent thrombosis should be regarded as manifestation of
Kounis syndrome.2. Stent thrombosis: a hypersensitivity
process
The bare metal stents have platform made of stainless steel,
which contains nickel, chromium, titanium, manganese, and
molybdenum, and the currently used drug eluting stents or
second generation stents have platforms of cobalt-chromium
and platinum-chromium that contain also nickel and other
metals. Their polymer coating, eluted drugs, aspirin and
thienopyridines which the stented patients are exposed to
together with any inadvertent environmental exposure are
acting all as strong antigenic complex able to induce an
allergic reaction and stent thrombosis.17 Stent thrombosis is
the result of serial adhesion, activation and aggregation of
platelets.18 Platelet adhesion starts when shear forces induce
extensions in platelet membrane (tethers) which bind tran-
siently to the injured coronary intima in an “on and off and
start and stop” fashion via interaction of the glucoprotein (GP)
Ib receptor with Von Willebrand Factor (VWF). This process is
called tethering and it is followed by platelet rolling which
is the result of interaction between GP VI receptor and
collagen.
Platelet activation takes place with stimulation of re-
ceptors for adenosine diphosphate, thromboxane, thrombin,
serotonin, epinephrine and some less known receptors such
as receptors for platelet activating factor, for histamine, for
high affinity and low affinity IgE receptors known as FCεRI and
FCεRII. During their activation platelets change shape from
discoid to spiculated form and release granules which
contain, proinflammatory, prothrombotic, adhesive and
aggregatory mediators. Platelet aggregation is the result of
binding of GP IIb/IIIa receptor with fibrinogen and interaction
with VWF. Thrombin converts fibrinogen to fibrin which
serves as a stable la´ttice for the creation of thrombus.
Therefore, receptors for hypersensitivity mediators are
also participating in platelet activation and these mediators
are derived from the allergic unit of eosinophils and mast
cells.19 This can explain why patients, as the described one,
can develop stent thrombosis during an allergic episode.3. Inadequacy of inotropes and volume
expansion to treat severe anaphylaxis
Experimental studieswith ovalbumin-sensitized guinea pigs20
have shown that soon after antigen administration,electrocardiogram shows signs of acute myocardial ischemia,
cardiac output is decreased by 90%, left ventricular end-dia-
stolic pressure rises indicating pump failure and arterial blood
pressure increases. Blood pressure starts declining steadily
after 4min. The authors of these experiments have concluded
that the rapid increase in left ventricular end-diastolic pres-
sure suggests that volume loss due to an increase in vascular
permeability and decreased venous return were unlikely to
have been the primary causes of the documented depression
in cardiac output. The view that the registered anaphylactic
cardiac damage might be due to peripheral vasodilatation
should be definitively excluded.20 Similar findings have been
reported by other authors.21,22 Furthermore, other experi-
ments have shown that severe impairment of the cerebral
blood flow takes place during anaphylactic shock which could
not be explained by the level of arterial hypotension and this
was attributed to early and direct action of anaphylactic me-
diators on cerebral vessels. In the clinical setting, there are
reports of patients with anaphylactic cardiac shock who do
not respond to intravenous fluid administration and anti-
allergic therapy but require treatment for acute coronary
event.23 In some patients, the administration of inotropes
worsened hypotension and eliminated cardiac output!.24 This
shows that in hypersensitivity, allergy and anaphylaxis the
heart and especially the coronary arteries are the primary
target and physicians should focused their attention on this
matter.
The same had occurred in the patient described in this
Journal in whom inotropes and blood expansion did not
improve his clinical symptoms, hemodynamics and electro-
cardiographic changes but he needed thrombolysis and
myocardial infarction therapy.4. Conclusion
Despite that life saving coronary stent implantation has
become themost frequently performed therapeutic procedure
in medicine,25 stented patients, are occasionally facing prob-
lems during their everyday life. These patients are exposed to
foreign substances inserted and being in direct touch with the
coronary intima. The most feared complication of stent
insertion is stent thrombosis with death rate up to 40%.
Although stent thrombosis is regarded as multifactorial
complication, procedural, clinical and angiographic variables
have been incriminated. Hypersensitivity to stent compo-
nents and to drugs the patients are taking after stent insertion
together with any environmental exposure seem to be some
of the main causes of stent thrombosis. Such exposures
include any allergy reactions, atopic diathesis and drugs.
Venoms from all the major snake families have been impli-
cated in the causation of allergic reactions.10 Stent
manufacturing companies have already taken protective and
defensive means by issuing official warnings and detailed
information, emphasizing the indications and contraindica-
tions for stent implantation. Physicians should read and
notice, before stent implantation, warnings of manufactures’
information sheets enclosed in the commercial stent pack-
ages of new generation stents.26
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